Biocytogen Pharmaceuticals-B(02315): Liu Hongkang appointed as non-executive director.

date
20:23 12/02/2026
avatar
GMT Eight
Bai Ao Sai Tu-B (02315) announced that, with the approval of the shareholders at the extraordinary general meeting, Mr. Liu Hongkang has been appointed as a non-executive director, effective from February 12, 2026 until the expiration of the second term of the board of directors.
Biocytogen Pharmaceuticals-B (02315) announced that Mr. Liu Hongkang has been appointed as a non-executive director, effective from February 12, 2026, and will serve until the end of the second term of the board of directors. At the board meeting held on January 27, 2026, the board of directors deliberated and approved the appointment of Mr. Liu as a non-executive director. Once approved by the shareholders, he will also serve as a member of the board's audit committee and strategic development committee. His term will begin from the date of his election as a non-executive director of the second term of the board, and will continue until the end of the second term.